Clinical Trial Update: Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions. [NA]

View source ↗

Summary

The study aims to identify biomarkers that distinguish malignant pancreatic lesions from benign pancreatic lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Neoplasms

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Benign Pancreatic Lesion | NA | Status: RECRUITING